These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [A new method of determining the rifampicin resistance of Mycobacterium tuberculosis]. Reutgen H. Acta Biol Med Ger; 1972; 28(3):395-409. PubMed ID: 4626094 [No Abstract] [Full Text] [Related]
6. [Studies on the antituberculous activities of rifampicin (REP) and the period of exposure in vitro (author's transl)]. Uratsuji Y. Bull Chest Dis Res Inst Kyoto Univ; 1978 Mar; 10(1-2):1-19. PubMed ID: 99200 [No Abstract] [Full Text] [Related]
9. Studies for the determination of clinically available criteria of resistance of tubercle bacilli to rifampicin. Gomi J, Yanagisawa K, Murohashi T. Kekkaku; 1970 Oct; 45(10):317-22. PubMed ID: 4991063 [No Abstract] [Full Text] [Related]
15. [In-vitro action of rifampicin on strains of tuberculous and atypical mycobacteria]. Denis-Bottin C. Acta Tuberc Pneumol Belg; 1972 Nov 15; 63(1):127-39. PubMed ID: 4631815 [No Abstract] [Full Text] [Related]
16. [Mode of action of rifampicin on Mycobacterium tuberculosis]. Konno K, Oizumi K, Hayashi I, Oka S. Kekkaku; 1972 Aug 15; 47(8):255-60. PubMed ID: 4634136 [No Abstract] [Full Text] [Related]